Literature DB >> 22586795

The urticarias: pathophysiology and management.

Clive Grattan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22586795      PMCID： PMC4954105          DOI： 10.7861/clinmedicine.12-2-164

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  20 in total

Review 1.  Chronic urticaria.

Authors:  M Greaves
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

2.  In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation.

Authors:  A Puccetti; C Bason; S Simeoni; E Millo; E Tinazzi; R Beri; D Peterlana; G Zanoni; G Senna; R Corrocher; C Lunardi
Journal:  Clin Exp Allergy       Date:  2005-12       Impact factor: 5.018

3.  Guidelines for evaluation and management of urticaria in adults and children.

Authors:  C E H Grattan; F Humphreys
Journal:  Br J Dermatol       Date:  2007-12       Impact factor: 9.302

4.  Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria.

Authors:  C E Grattan; D M Francis; M Hide; M W Greaves
Journal:  Clin Exp Allergy       Date:  1991-11       Impact factor: 5.018

5.  Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids.

Authors:  Eduardo Shahar; Reuven Bergman; Emma Guttman-Yassky; Shimon Pollack
Journal:  Int J Dermatol       Date:  2006-10       Impact factor: 2.736

6.  Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

Authors:  C E Grattan; B F O'Donnell; D M Francis; N Niimi; R J Barlow; P T Seed; A Kobza Black; M W Greaves
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

7.  TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.

Authors:  Sun Ying; Yoko Kikuchi; Qiu Meng; A Barry Kay; Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2002-04       Impact factor: 10.793

8.  EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.

Authors:  T Zuberbier; R Asero; C Bindslev-Jensen; G Walter Canonica; M K Church; A Giménez-Arnau; C E H Grattan; A Kapp; H F Merk; B Rogala; S Saini; M Sánchez-Borges; P Schmid-Grendelmeier; H Schünemann; P Staubach; G A Vena; B Wedi; M Maurer
Journal:  Allergy       Date:  2009-10       Impact factor: 13.146

9.  Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.

Authors:  John A Eckman; Robert G Hamilton; Laura M Gober; Patricia M Sterba; Sarbjit S Saini
Journal:  J Invest Dermatol       Date:  2008-03-20       Impact factor: 8.551

Review 10.  Autoimmune urticaria.

Authors:  Clive E H Grattan
Journal:  Immunol Allergy Clin North Am       Date:  2004-05       Impact factor: 3.479
View more
  2 in total

1.  A case series study of eighty-five chronic spontaneous urticaria patients referred to a tertiary care center.

Authors:  Line Kibsgaard; Anna Cecile Lefevre; Mette Deleuran; Christian Vestergaard
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

2.  Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.

Authors:  P Staubach; M Metz; N Chapman-Rothe; C Sieder; M Bräutigam; M Maurer; K Weller
Journal:  Allergy       Date:  2017-12-11       Impact factor: 13.146
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.